To enhance tumor specificity, IR‐BTOG was further optimized by integrating the Glypican 3 peptide (GPC3 peptide)‐targeting strategy, resulting in the formation of BTOGP‐GPC3 nanoparticles (NPs) (Scheme 1b). This evidence concerns the gene GPC3 and neoplasm.